US Patent 11617752 Methods for increasing sepiapterin plasma exposure
Patent 11617752 was granted and assigned to PTC Therapeutics on April, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jonathan Reis0
Neil Smith0
Edits on 8 Apr, 2023
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+297 characters)
US Patent 11617752 Methods for increasing sepiapterin plasma exposure
Article
The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma, CSF, and/or brain exposure of sepiapterin.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116177520
Date of Patent
April 4, 2023
0Patent Application Number
170597190
Date Filed
May 30, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11617752 Methods for increasing sepiapterin plasma exposure
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
